Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without BRCA Mutation Eligible patients ...
This multicenter, prospective study (ClinicalTrials.gov identifier: NCT04703153) enrolled patients across the United States and Singapore. Patients were tested with tissue NGS, LHM, and G360 ctDNA.
Federally funded research suggests that standardizing what defines contamination could increase accuracy of diagnoses, optimize treatments, avoid unnecessary medications and improve patient outcomes ...
PainTEQ, a leader in minimally invasive solutions for chronic pain, today announced enrollment of the first patient in the TRAQTION Study, a prospective, multicenter clinical study evaluating outcomes ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果